Stay updated on Intravenous Sulbactam-ETX2514 for Acinetobacter Infections Clinical Trial
Sign up to get notified when there's something new on the Intravenous Sulbactam-ETX2514 for Acinetobacter Infections Clinical Trial page.

Latest updates to the Intravenous Sulbactam-ETX2514 for Acinetobacter Infections Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check21 days agoChange DetectedThe web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference1%
- Check50 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check64 days agoChange DetectedThe page has undergone significant revisions, including the removal of detailed study descriptions and inclusion/exclusion criteria for a clinical trial involving Acinetobacter Baumannii infections, while retaining some core information about the study's masking procedures and revision number.SummaryDifference22%
- Check72 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check79 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
Stay in the know with updates to Intravenous Sulbactam-ETX2514 for Acinetobacter Infections Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Intravenous Sulbactam-ETX2514 for Acinetobacter Infections Clinical Trial page.